FDA’s tobacco program must be proactive, not reactive, independent panel says after extensive review

An independent panel of experts says its review of the US Food and Drug Administration’s tobacco program found numerous wide-ranging problems that hinder its ability to regulate the industry and reduce tobacco-related disease and death.

(SOURCE) https://www.cnn.com/2022/12/19/health/fda-tobacco-review/index.html

Share:


Related Posts

Elon Musk says Twitter deal can't happen until bot account dispute is resolved

Elon Musk escalated a public feud with Twitter’s CEO early Tuesday, saying his...

Are Republicans about to blow a Senate seat?

It should be easy to elect a Republican in Missouri, but former governor...

Leave a Comment

Your email address will not be published. Required fields are marked *

Add Comment *

Name *

Email *

Website